Agenus Inc. (AGEN) Shareholder Derivative Lawsuit

Jan 20, 2025 | KLF Blog

Agenus Inc. Shareholder Derivative Complaint (AGEN) 

A shareholder derivative complaint was filed on January 15, 2025, against certain officers and directors of Agenus Inc. (NASDAQ: AGEN), alleging violations of state and federal law which occurred between January 23, 2023, and July 17, 2024. View the Agenus complaint.

If you own shares of Agenus, you may have legal claims against the company’s directors and officers.

To help us assess your legal options, please complete our securities questionnaire. Alternatively, if you would like to discuss the case and your legal rights, click here to send us a message or contact Michael Yarnoff, Esq., at (215) 792-6676, Ext. 804, or by email at [email protected] or [email protected], for a free, no-obligation evaluation of your potential claims.

Kehoe Law Firm, P.C. is a leading, multidisciplinary plaintiff-side class action law firm committed to protecting investors from securities fraud, breaches of fiduciary duty, and corporate misconduct. The firm’s partners have collectively served as Lead Counsel or Co-Lead Counsel in high-profile cases that have secured over $10 billion in recoveries for both institutional and individual investors.

For more information, visit our website at Kehoe Law Firm, P.C.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Innovative Industrial Properties Securities Class Action (IIPR)

Jan 20, 2025 | Investigations

On January 17, 2025, a class action lawsuit was filed against Innovative Industrial Properties, Inc. (“IIPR” or the “Company”) (NYSE: IIPR) on behalf of investors who acquired IIPR securities between February 27, 2024, and December 19, 2024 (the “Class Period”).

If you purchased or otherwise acquired IIPR shares during the Class Period, click here to send us a message for more information about the IIPR class action lawsuit.

How to Provide Information

To share details about your financial losses or to be contacted by a member of our team, please complete our brief securities questionnaire. Alternatively, you can reach out to Michael Yarnoff, Esq., for a no-obligation evaluation of potential legal claims:

Class Action Lawsuit Allegations

According to the complaint, the defendants allegedly made materially false and misleading statements about the Company’s business, operations, and financial prospects during the Class Period. Specifically, the complaint alleges the following:

  1. IIPR was experiencing significant declines in rent and property-management fees associated with certain customer leases.
  2. These declines would likely impair the Company’s ability to maintain funds from operations (FFO) and revenue growth.
  3. Consequently, IIPR’s leasing operations were less profitable than the Company had represented to investors.
  4. As a result, IIPR’s public statements were materially false and misleading throughout the Class Period.

To review the complaint, click IIPR class action complaint.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C., is a multidisciplinary, plaintiff-side class action law firm committed to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Collectively, the firm’s partners have served as Lead or Co-Lead Counsel in cases recovering over $10 billion on behalf of institutional and individual investors.

 

 

 

Please submit this form if you have incurred financial losses.

By clicking and submitting this form, you acknowledge that this does not establish an attorney-client relationship between you and Kehoe Law Firm, P.C. (“KLF” or “Firm”), and that the submission or receipt of information to the Firm or one of its attorneys via this form, website, email or telephone does not create an attorney-client relationship.  All submissions are confidential, and there is no cost or obligation incurred by providing your information to Kehoe Law Firm, P.C. By submitting this form, you authorize KLF to contact you regarding this or future cases. 

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Walgreens Securities Investigation (WBA)

Jan 18, 2025 | Investigations

Kehoe Law Firm, P.C. is investigating securities class action claims on behalf of shareholders of Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA).

WALGREENS INVESTORS WITH FINANCIAL LOSSES ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. FOR A FREE, NO OBLIGATION EVALUATION OF POTENTIAL LEGAL CLAIMS.

Investors of Walgreens should be aware that the U.S. Department of Justice (“DOJ”) has filed a civil complaint in federal court alleging that Walgreens Boots Alliance, Walgreen Co. and various subsidiaries dispensed millions of unlawful prescriptions in violation of the Controlled Substances Act (“CSA”) and then sought reimbursement for many of these prescriptions from various federal health care programs in violation the False Claims Act (“FCA”).

According to the complaint, “. . . from approximately August 2012 through the present, Walgreens knowingly filled millions of prescriptions for controlled substances that lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice. Among the millions of unlawful prescriptions that Walgreens allegedly filled were prescriptions for dangerous and excessive quantities of opioids, prescriptions for early refills of opioids and prescriptions for the especially dangerous and abused combination of drugs known as the ‘trinity,’ which is made up of an opioid, a benzodiazepine and a muscle relaxant.”

On this news, the stock price of Walgreens dropped more than 5% after the stock market closed on January 17, 2025.

WALGREENS SHAREHOLDERS INTERESTED IN LEARNING MORE ABOUT THE SECURITIES CLASS ACTION INVESTIGATION CAN ALSO EMAIL [email protected] OR CONTACT EITHER JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected].

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Comerica Inc. – Breach of Fiduciary Duties Investigation (CMA)

Jan 15, 2025 | Investigations

Kehoe Law Firm, P.C. is invesigating whether certain executive officers or board members of Comerica Inc. (“Comerica”) (NYSE: CMA) failed to manage Comerica in an acceptable manner, in breach of their fiduciary duties to Comerica, and whether Comerica and its shareholders were harmed as a result.

CURRENT INVESTORS OF COMERICA STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. FOR A FREE EVALUATION OF POTENTIAL LEGAL CLAIMS.

CFPB v. Comerica Bank

On December 6, 2024, the Consumer Financial Protection Bureau (“CFPB”) sued Comerica Bank, a subsidiary of publicly traded Comerica Inc., for systematically failing its 3.4 million Direct Express cardholders – primarily unbanked Americans receiving federal benefits.

Comerica Bank, according to the CFPB, deliberately disconnected 24 million customer service calls, impeding cardholders from exercising their rights under the law, charged illegal ATM fees to over 1 million cardholders, and mishandled fraud complaints while providing federal benefits through the Direct Express prepaid debit card program.

Key CFPB Lawsuit Allegations About How Comerica Harmed its Customers:

  • Deliberately disconnecting customer service calls: Comerica’s vendors intentionally dropped more than 24 million calls from customers before they could reach a representative. Customers whose calls were not dropped were routinely forced to endure excessively long wait times—often in excess of several hours—to speak with a representative to get help with unauthorized transactions, charge disputes, and lost or stolen cards.
  • Charging consumers illegal ATM fees: Over one million Direct Express cardholders were charged ATM fees to access their government benefits in situations where they were legally entitled to free withdrawals.
  • Misleading fraud victims: When consumers contacted Comerica alleging they had been fraudulently enrolled into the Direct Express program, the bank’s vendors frequently advised the consumers that “no error occurred” where the bank had determined that there was, in fact, enrollment fraud.
  • Imposing illegal terms of service on consumers seeking to stop payments: Comerica led its consumers to agree to waive their consumer protections by requiring cardholders to contact and request merchants to stop pre-authorized payment transfers from their account in situations where the law in fact required the bank to stop the transfers itself.
  • Failing to investigate account problems: Under federal law, when a customer notifies a bank about an incorrect or potentially fraudulent charge on their account, the bank must take steps to investigate the error within a specified time period. The CFPB’s investigation found that Comerica failed to meet this requirement more than 20,000 times. And when they did investigate, they frequently provided vague and confusing findings or blew off customers altogether.
  • Forcing consumers to close accounts, which often resulted in additional fees: The bank’s vendors required thousands of cardholders to close their accounts to stop a preauthorized payment, resulting in consumers incurring additional fees to expedite receipt of their new debit cards to regain access to their government benefits.

Read the CFPB complaint by clicking CFPB v. Comerica Bank.

COMERICA SHAREHOLDERS ALSO CAN CLICK HERE, EMAIL [email protected], OR CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected] TO LEARN MORE ABOUT THE COMERICA BREACH OF FIDUCIARY DUTIES INVESTIGATION.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Aehr Test Systems Securities Class Action (AEHR)

Jan 14, 2025 | KLF Blog

AEHR TEST SYSTEMS, INC. (NASDAQ: AEHR) – Lucid Alternative Fund, LP v. Aehr Test Systems, et al., 3:24-cv-08683 (Dec. 3, 2024, N.D. Cal.)

On December 3, 2024, a federal securities class action was filed on behalf of investors that acquired Aehr Test Systems securities between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ alleged violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Learn more about this case by clicking Aehr Test Systems complaint.

If you own AEHR stock and have questions about potential legal claims, please email us at [email protected] or complete our Securities Class Action Questionnaire. All submissions are confidential, evaluations of potential legal claims are free, and there is no obligation to take further action.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]